Member login

Forgot Password?
Return to login
Back to News index

British Biosimilars Association (BBA) Stakeholder Forum, Tuesday, November 21

Venue: First floor, 65 Gresham Street, London EC2V 7NQ

On November 21, the British Biosimilars Association (BBA) will be staging its second annual conference looking at the latest clinical best practice in the use and uptake of biosimilars within the NHS. The key note speakers will be Peter Huskinson, Commercial Director and Suzy Heafield, Commercial Pharmacy Medicines Optimisation Lead at NHS England. Further discussion panels will take place throughout the day aimed at sharing best practice and experience.

Confirmed speakers / participants include:

  • Julie Wood, Chief Executive, NHS Clinical Commissioners
  • Tim Root, Strategic Lead, Medicines Optimisation and Pharmacy Procurement, NHS LPP
  • Katy Pilling, Deputy Head of Prescribing, East Leicestershire and Rutland Clinical Commissioning Group
  • Steve Williamson, Chair of the British Oncology Pharmacy Association
  • Jatinder Harchowal/Tim McCarthy, The Cancer Vanguard
  • Lymphoma Association
  • Andrew Davies, Professional Lead for Hospital Pharmacy, NHS Improvement
  • James Kent, Specialist Procurement Pharmacist, London & East of England

The event starts at 9.30am and is free to attend. To register a place, please email

Download 278.6 KB